A Urologist with Advanced Prostate Cancer Shares His Story
The following was sent to me as a comment to a prior post. Instead, I think the comment warrants being put up as its own separate post. It is written by a urologist who has [...]
On The Horizon- Interventional Radiology Treatments For Recurrent Prostate Cancer
Some interesting information was presented at the Society of Interventional Radiology’s 35th Annual Scientific Meeting just held in Tampa, Fl. A potential future use of magnetic resonance (MR)-guided heat (laser interstitial thermal therapy) or cold [...]
Stamped- Best By; Sell By & Expires By
The doctors told me that I have recurrent prostate cancer, they stamped on my forehead a little sign that says “EXPIRES ??/??/20??. I have tried and tried to wash that stamp off my face. No [...]
Malpractice and Withholding PSA Tests
I have been reading in the press about a recent medical malpractice settlement surrounding prostate cancer. Briefly, a man went to his primary care physician who, along with other tests, performed a DRE and PSA [...]
Avastin for Prostate Cancer – Looks Like It Isn’t Going To Happen
Roche Pharmaceuticals has reported that their clinical trial of Avastin in men with advanced prostate cancer did not improve their overall life expectancy. […]
The FDA Has Approved TRELSTAR(R) 22.5 mg, The First 6-Month GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
Watson Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Trelstar – 22.5 mg (triptorelin pamoate for injectable suspension) at a dosage which will be required only to be administered twice [...]